KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Accumulated Expenses (2016 - 2025)

Quest Diagnostics' Accumulated Expenses history spans 14 years, with the latest figure at $338.0 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 10.46% to $338.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $338.0 million, a 10.46% increase, with the full-year FY2025 number at $338.0 million, up 10.46% from a year prior.
  • Accumulated Expenses hit $338.0 million in Q4 2025 for Quest Diagnostics, up from $306.0 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for DGX hit a ceiling of $460.0 million in Q4 2021 and a floor of $287.0 million in Q4 2023.
  • Historically, Accumulated Expenses has averaged $356.6 million across 5 years, with a median of $338.0 million in 2025.
  • Biggest five-year swings in Accumulated Expenses: grew 29.21% in 2021 and later decreased 26.79% in 2023.
  • Tracing DGX's Accumulated Expenses over 5 years: stood at $460.0 million in 2021, then dropped by 14.78% to $392.0 million in 2022, then dropped by 26.79% to $287.0 million in 2023, then increased by 6.62% to $306.0 million in 2024, then increased by 10.46% to $338.0 million in 2025.
  • Business Quant data shows Accumulated Expenses for DGX at $338.0 million in Q4 2025, $306.0 million in Q4 2024, and $287.0 million in Q4 2023.